2022 NHMRC Investigator Grant success!

"Inflammasome inhibitors as new first-in-class anti-inflammatory therapies” 

2022 NHMRC Investigator Grant success!

16 Sep 21 schroder.admin Funding 0 Comments

2022 NHMRC Investigator Grant

Inflammation drives many devastating human diseases, and there are currently no effective treatments for many such diseases.

Kate's research program aims to leverage her validated discovery and development pipeline to deliver new first-in-class anti-inflammatory drugs to treat devastating diseases such as chronic liver disease and inflammatory bowel disease. 

Congratulations Kate!

Posted by schroder.admin

ABOUT Inflammasome Lab

Inflammasome Lab is a group of researchers led by Prof Kate Schroder at the Institute for Molecular Bioscience, The University of Queensland.
We seek to unravel the secrets of inflammasomes – protein complexes at the heart of inflammation and disease – to allow for new therapies to fight human diseases.